The Severe Von Willebrand Disease (sVWD) Patient Registry

Description

A web-based registry will be created by the sponsor, VWD Connect Foundation (VCF), to collect data on patients with severe Von Willebrand Disease (sVWD). Data will be self-reported by patients and/or collected by registry personnel, as appropriate. The purpose of the sVWD Patient Registry is to create a database of well-characterized (with respect to demographics, medical history, symptoms, laboratory and genetic data, etc.) patients with sVWD for participation in retrospective and prospective research.

Conditions

VWD - Von Willebrand's Disease

Study Overview

Study Details

Study overview

A web-based registry will be created by the sponsor, VWD Connect Foundation (VCF), to collect data on patients with severe Von Willebrand Disease (sVWD). Data will be self-reported by patients and/or collected by registry personnel, as appropriate. The purpose of the sVWD Patient Registry is to create a database of well-characterized (with respect to demographics, medical history, symptoms, laboratory and genetic data, etc.) patients with sVWD for participation in retrospective and prospective research.

The Severe Von Willebrand Disease Patient Registry: A Longitudinal Natural History and Patient Outcomes Study

The Severe Von Willebrand Disease (sVWD) Patient Registry

Condition
VWD - Von Willebrand's Disease
Intervention / Treatment

-

Contacts and Locations

Wellington

VWD Connect Foundation, Wellington, Florida, United States, 33414

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Have a clinical diagnosis of Von Willebrand Disease (VWD) with any Von Willebrand factor level(s) \< 20%
  • * Provide informed consent by participant or legally authorized representative
  • * Be willing and able to comply with study procedures and data collection
  • * Reside in the United States
  • * Have a clinical diagnosis of acquired VWD

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

VWD Connect Foundation,

Christopher Walsh, MD, PhD, PRINCIPAL_INVESTIGATOR, Mt. Sinai School of Medicine

Mrinal Gounder, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Christina Morgenthaler, MS, MBA, PRINCIPAL_INVESTIGATOR, VWD Connect Foundation

Alice Arapshian, PRINCIPAL_INVESTIGATOR, VWD Connect Foundation

Study Record Dates

2027-01